MedPath

Investigation of the pathogenesis of type 1 and insulin-dependent diabetes mellitus using a noninvasive pancreatic beta cell imaging technique

Phase 2
Recruiting
Conditions
Type 1 diabetes mellitus
D003922
Registration Number
JPRN-jRCT1051220023
Lead Sponsor
Murakami Takaaki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1) Clinically diagnosed with type 1 diabetes mellitus or recognized as insulin-dependent diabetes mellitus
2) Aged 20 years or older at the time of the informed consent
3) Written consent has been obtained from the subject for participation in this study

Exclusion Criteria

1) Patients have severe liver or kidney dysfunction
2) Inability to discontinue GLP-1 related products
3) Patients who are unsuitable or contraindicated for exenatide administration
4) Patients with alcohol intolerance
5) Patients who were judged to be inappropriate for enrolment by the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath